LUNAC Therapeutics-led project awarded £3.14m under Innovate UK Biomedical Catalyst Programme, to develop next-generation anticoagulant

This article was originally published here

The funding will be used to develop an innovative anticoagulant treatment with minimal bleeding risk, to better meet patient need. The 18-month preclinical drug discovery project brings together

The post LUNAC Therapeutics-led project awarded £3.14m under Innovate UK Biomedical Catalyst Programme, to develop next-generation anticoagulant appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply